Colony Group LLC Abb Vie Inc. Transaction History

Colony Group LLC

$6.66 Billion
Q3 2023

A detailed history of Colony Group LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Colony Group LLC holds 153,892 shares of ABBV stock, worth $27.7 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

153,892

Previous 154,105 0.14%

Holding current value

$27.7 Million

Previous $20.8 Million 10.48%

% of portfolio

0.34%

Previous 0.29%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $28,454 - $32,940	-213 Reduced 0.14%	153,892 $22.9 Million
Q2 2023 Aug 15, 2023	SELL	$132.51 - $164.9 $666,657 - $829,611	-5,031 Reduced 3.16%	154,105 $20.8 Million
Q1 2023 May 16, 2023	SELL	$144.61 - $166.54 $1.47 Million - $1.69 Million	-10,172 Reduced 6.01%	159,136 $25.4 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $380,629 - $456,474	2,752 Added 1.65%	169,308 $27.4 Million
Q3 2022 Nov 15, 2022	SELL	$134.21 - $153.93 $652,797 - $748,715	-4,864 Reduced 2.84%	166,556 $22.4 Million
Q2 2022 Aug 16, 2022	BUY	$137.62 - $174.96 $2.23 Million - $2.84 Million	16,223 Added 10.45%	171,420 $26.3 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $12.3 Million - $15.2 Million	92,995 Added 149.5%	155,197 $25.2 Million
Q4 2021 Feb 15, 2022	BUY	$107.43 - $135.93 $3.22 Million - $4.07 Million	29,939 Added 92.8%	62,202 $8.42 Million
Q3 2021 Nov 17, 2021	SELL	$106.4 - $120.78 $13,938 - $15,822	-131 Reduced 0.4%	32,263 $3.48 Million
Q2 2021 Aug 18, 2021	SELL	$105.21 - $117.21 $128,040 - $142,644	-1,217 Reduced 3.62%	32,394 $3.65 Million
Q1 2021 May 21, 2021	BUY	$102.3 - $112.62 $158,258 - $174,223	1,547 Added 4.82%	33,611 $3.64 Million
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $287,832 - $388,603	-3,576 Reduced 10.03%	32,064 $3.44 Million
Q3 2020 Nov 17, 2020	BUY	$85.91 - $100.83 $332,729 - $390,514	3,873 Added 12.19%	35,640 $3.12 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $115,777 - $154,928	1,578 Added 5.23%	31,767 $3.12 Million
Q1 2020 May 18, 2020	BUY	$64.5 - $97.79 $134,418 - $203,794	2,084 Added 7.42%	30,189 $2.3 Million
Q4 2019 Feb 18, 2020	BUY	$72.13 - $90.25 $278,998 - $349,087	3,868 Added 15.96%	28,105 $2.49 Million
Q3 2019 Nov 26, 2019	SELL	$62.98 - $75.72 $295,439 - $355,202	-4,691 Reduced 16.22%	24,237 $1.84 Million
Q2 2019 Aug 19, 2019	BUY	$65.7 - $83.98 $500,305 - $639,507	7,615 Added 35.73%	28,928 $2.1 Million
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $896,135 - $1.05 Million	11,617 Added 119.81%	21,313 $1.72 Million
Q4 2018 Feb 15, 2019	SELL	$77.85 - $96.01 $11,210 - $13,825	-144 Reduced 1.46%	9,696 $894,000
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $10,758 - $11,959	121 Added 1.24%	9,840 $931,000
Q2 2018 Aug 15, 2018	BUY	$89.78 - $106.23 $89 - $106	1 Added 0.01%	9,719 $900,000
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $463,086 - $620,115	5,033 Added 107.43%	9,718 $920,000
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $107,919 - $118,343	1,205 Added 34.63%	4,685 $453,000
Q3 2017 Nov 15, 2017	BUY	$69.85 - $89.22 $243,077 - $310,485	3,480	3,480 $309,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Colony Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Colony Group LLC with notifications on news.

Account